82 FR 35547 - Importer of Controlled Substances Application: Sigma-Aldrich International GMBH

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 82, Issue 145 (July 31, 2017)

Page Range35547-35548
FR Document2017-16059

Federal Register, Volume 82 Issue 145 (Monday, July 31, 2017)
[Federal Register Volume 82, Number 145 (Monday, July 31, 2017)]
[Notices]
[Pages 35547-35548]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-16059]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: Sigma-Aldrich 
International GMBH

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.34(a) on or before August 30, 2017. Such persons may also file a 
written request for a hearing on the application pursuant to 21 CFR 
1301.43 on or before August 30, 2017.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
request for hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, 
Springfield, Virginia 22152. Comments and requests for hearings on 
applications to import narcotic raw material are not appropriate. 72 FR 
3417, (January 25, 2007).

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix of subpart R.
    In accordance with 21 CFR 1301.34(a), this is notice that on 
January 19, 2016, Sigma-Aldrich International GMBH, Sigma Aldrich Co. 
LLC, 3500 Dekalb Street, Saint Louis, Missouri 63118 applied to be 
registered as an importer of the following basic classes of controlled 
substances:

------------------------------------------------------------------------
        Controlled substance            Drug code          Schedule
------------------------------------------------------------------------
Cathinone..........................            1235  I
Methcathinone......................            1237  I
Mephedrone (4-Methyl-N-                        1248  I
 methylcathinone).
N-Ethylamphetamine.................            1475  I
Aminorex...........................            1585  I
Gamma Hydroxybutyric Acid..........            2010  I

[[Page 35548]]

 
Methaqualone.......................            2565  I
Alpha-ethyltryptamine..............            7249  I
Ibogaine...........................            7260  I
Lysergic acid diethylamide.........            7315  I
Marihuana..........................            7360  I
Tetrahydrocannabinols..............            7370  I
Mescaline..........................            7381  I
4-Bromo-2,5-dimethoxyamphetamine...            7391  I
4-Bromo-2,5-dimethoxyphenethylamine            7392  I
4-Methyl-2,5-dimethoxyamphetamine..            7395  I
2,5-Dimethoxyamphetamine...........            7396  I
3,4-Methylenedioxyamphetamine......            7400  I
N-Hydroxy-3,4-                                 7402  I
 methylenedioxyamphetamine.
3,4-Methylenedioxy-N-                          7404  I
 ethylamphetamine.
3,4-Methylenedioxymethamphetamine..            7405  I
4-Methoxyamphetamine...............            7411  I
Bufotenine.........................            7433  I
Diethyltryptamine..................            7434  I
Dimethyltryptamine.................            7435  I
Psilocybin.........................            7437  I
Psilocyn...........................            7438  I
1-[1-(2-                                       7470  I
 Thienyl)cyclohexyl]piperidine.
N-Benzylpiperazine.................            7493  I
MDPV (3,4-                                     7535  I
 Methylenedioxypyrovalerone).
Butylone...........................            7541  I
Heroin.............................            9200  I
Normorphine........................            9313  I
Etonitazene........................            9624  I
Amobarbital........................            2125  II
Pentobarbital......................            2270  II
Secobarbital.......................            2315  II
Glutethimide.......................            2550  II
Nabilone...........................            7379  II
Phencyclidine......................            7471  II
Diphenoxylate......................            9170  II
Ecgonine...........................            9180  II
Ethylmorphine......................            9190  II
Levorphanol........................            9220  II
Meperidine.........................            9230  II
Thebaine...........................            9333  II
Opium, powdered....................            9639  II
Levo-alphacetylmethadol............            9648  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
sale to research facilities for drug testing and analysis.

    Dated: July 24, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-16059 Filed 7-28-17; 8:45 am]
 BILLING CODE 4410-09-P


Current View
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of application.
DatesRegistered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before August 30, 2017. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before August 30, 2017.
FR Citation82 FR 35547 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR